Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MUSE: Atorvastatin Muscle Side-Effects in Coronary Patients
NCT03874156Phase 4Completed
- Sponsor
- Vestre Viken Hospital Trust
- Start
- Mar 2019
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of atorvastatin in coronary heart disease (CHD) (3 arms), sponsored by Vestre Viken Hospital Trust. Primary endpoint: Visual Analogue Scale for Muscular Symptom Intensity at 16 weeks. Started Mar 2019; status: completed.
02
Drugs
atorvastatin
03
Conditions
coronary heart disease (CHD)
Beyond the preview
Go deeper on NCT03874156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03874156.